Japan Acute Myocardial Infarction Registry

Japan Acute Myocardial Infarction Registry - JAMIR prospective study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000019479

Enrollment

3000

Registered

2015-11-01

Start date

2015-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myocardial infarction

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed as acute myocardial infarction by universal definition or MONICA criteria (Universal definition) Patients who satisfies one of the followings as well as find out rising myocardial deviation enzyme (Myocardial TOROPONIN is desirable.) - The symptom of the ischemia - New ST-T change or newly emerged left leg block - Emerging an abnormal Q-wave in an electro cardiogram - Confirmed either viable myocardium deviation or emerging new wall motion abnormality within the electro cardiogram. - Confirmed thrombosis image within the coronary artery, either angiography or necropsy examination (MONICA criteria) More than 2 times of rise of the normal upper limit of the Creatinine kinase MB. Or one of followings are satisfied while more than 2 times of rise of normal upper limit of Creatinine phosphokinase observed. - The symptom of the myocardial ischemia - Emerging an abnormal Q-wave in an electrocardiogram - Either Rise of descent found among ST part within an electro-cardiogram

Exclusion criteria

Exclusion criteria: (1)Patients who developed acute myocardial infarction as a complication by PCI (2)Patients who developed acute myocardial infarction after GABG as a perioperative complication (3) Patients with delay of greater than or equal to 24 hours between onset of myocardial infarction and hospital admission (4) Patients with prehospital cardiopulmonary arrest who are in state of continuous cardiopulmonary arrest on admission

Design outcomes

Primary

Measure	Time frame
Ischemic event (cardiovascular death + nonfatal myocardial infarction + nonfatal cerebral infarction). Bleeding event (TIMI hemorrhage and BARC type 3+5)	—

Secondary

Measure	Time frame
Ischemic event (cardiovascular death + nonfatal myocardial infarction+ nonfatal cerebral infarction) + Bleeding event (TIMI hemorrhage) complex endpoint, nonfatal myocardial infarction, nonfatal cerebral infarction, cardiovascular death, overall death, stent thrombosis. Bleeding event( TIMI hemorrhage+ small bleeding, BARC type 2+3+5) ,Re-hospitalization by heart failure	—

Countries

Japan

Contacts

Public ContactTadakazu Inoue

Quintiles Transnational Japan K.K. Outcome Group Medical Affairs & Clinical Science

Tadakazu.Inoue@quintiles.com06-4807-9800

Outcome results